Viscoelastic Haemostasis
[Viscoelastic Haemostasis]
EPTIS factsheet 1176653 | Last revision 2024-05-22 | URL: https://www.eptis.bam.de/pts1176653 https://www.eptis.bam.de/pts1176653
| PT provider | ||||||||||||||||||||||||||||
| PT provider | Weqas Weqas | |||||||||||||||||||||||||||
| Based in | United Kingdom | |||||||||||||||||||||||||||
| Language(s) | ||||||||||||||||||||||||||||
| Remarks | The Programme is aimed at clinical staff using Point of Care (POCT) devices such as the ROTEM Sigma and TEG 6 devices rather than laboratory personnel using Thromboelastometry (ROTEM Delta) or Thromboelastography (TEG) analysers. The Programme assesses the performance of the devices and the clinical teams in correctly identifying the specific parameters used in the treatment and transfusion algorithms for the different clinical pathways. Two Lyophilized human citrated plasma samples (including those enriched with unfractionated Heparin) are distributed every 3 months. The Programme assesses the performance criteria relating to qualitative and quantitative analytes. For quantitative analysis, bias and impression are assessed. This programme is provided in collaboration with the External quality Control of diagnostic Assays and tests foundation in the Netherlands (ECAT). The ECAT foundation is a non-profit organisation providing an international EQA for laboratories working in the field of haemostasis and thrombosis. Samples are shared between the two providers as are the anonymised results. This allows for a larger peer group assessment of the results in this highly specialised field. Key Features: - Working in collaboration with ECAT. - Large peer group assessment. - Suitable for TEG and TEM. - Covers the major analytes used in postpartum haemorrhage, post cardiac surgery and major trauma. - Milan Model 3 analytical performance specifications used. For more information: https://www.weqas.com/services/poct-eqa/viscoelastic-haemostasis/ or contact@weqas.com | |||||||||||||||||||||||||||
| Keywords | ||||||||||||||||||||||||||||
| Product groups |
Health care / medical devices
|
|||||||||||||||||||||||||||
| Testing fields |
Medical analysis
|
|||||||||||||||||||||||||||
| Technical details | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Aims of the PT scheme | ||||||||||||||||||||||||||||
| Target group of participants | The Programme is aimed at clinical staff using Point of Care (POCT) devices such as the ROTEM Sigma and TEG 6 devices rather than laboratory personnel using Thromboelastometry (ROTEM Delta) or Thromboelastography (TEG) analysers. | |||||||||||||||||||||||||||
| Linked to specific legislation / standards | Accreditation by UKAS based on ISO/IEC 17043. | |||||||||||||||||||||||||||
| Additional, subsidiary aims | characterisation of reference materials and validation of testing methods | |||||||||||||||||||||||||||
| Number of participants | ||||||||||||||||||||||||||||
| Accredited or otherwise reviewed by a 3rd party |
Accredited by UKAS on the basis of ISO/IEC 17043 |
|||||||||||||||||||||||||||
| Operation is commissioned / requested by | ||||||||||||||||||||||||||||
| Fees and frequency | ||||||||||||||||||||||||||||
| Participation fee | https://www.weqas.com/participantzone/subscription-charges/ | |||||||||||||||||||||||||||
| Regularly operated | Yes (Frequency: Quarterly. Samples: 2 x 3.0mL. ) | |||||||||||||||||||||||||||
| Year of first operation | 2020 | |||||||||||||||||||||||||||
| Contact details of the PT provider | ||||||||||||||||||||||||||||
| Provider | Contact person | |||||||||||||||||||||||||||
|
Weqas
Unit 6, Parc Ty Glas CF14 5DU Cardiff United Kingdom Phone: 44 (0) 2920 314750 Fax: Web: http://www.weqas.com http://www.weqas.com |
Laura Lloyd-Lewis
Phone: 44 (0) 29218 32884 Fax: Email: laura.lloyd-lewis@wales.nhs.uk laura.lloyd-lewis@wales.nhs.uk |
|||||||||||||||||||||||||||
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.